Medicare billing address
CMS Medicare provider billing file
Penn State Health Milton S. Hershey Medical Center500 University Drive
Hershey, PA 17033
CMS public data · NPI 1245722842
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Ashok Maddukuri, MD
Specialty
Credential
MD
NPI
1245722842
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Ashok Maddukuri, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
Penn State Health Milton S. Hershey Medical CenterCMS Doctors & Clinicians file
1120 Cocoa AveCMS Doctors & Clinicians file
2200 Good Hope RdCMS Doctors & Clinicians file
2200 Good Hope RdIn the 2024 CMS provider billing file, this NPI had 182 Medicare beneficiaries and 17,428 total services. The average beneficiary age was 77, and the average HCC risk score was 2.
Total Medicare allowed amount
$617,965.58
Total Medicare payment amount
$494,505.69
Medicare beneficiaries
182
Total services
17,428
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Chronic kidney disease
36%
CMS beneficiary-panel share
Ischemic heart disease
36%
CMS beneficiary-panel share
Diabetes
35%
CMS beneficiary-panel share
Mood disorders
24%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, denosumab, 1 mg | 1,080 | $26.39 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 850 | $7.72 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 171 | $7.61 |
| Insertion of needle into vein for collection of blood sample | 168 | $6.86 |
| Blood test, comprehensive group of blood chemicals | 108 | $10.35 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 53 | $86.02 |
| Injection of drug or substance under skin or into muscle | 48 | $13.46 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 41 | $121.48 |
| Ferritin (blood protein) level | 38 | $13.36 |
| Iron level | 38 | $6.34 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1245722842. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Eliquis | Apixaban | 14 | 22 | $11,932.52 |
| 2 | Gabapentin | Gabapentin | 14 | 18 | $91.89 |
| 3 | Ondansetron Odt | Ondansetron | 12 | 12 | $168.54 |
| 4 | Inlyta | Axitinib | 11 | 11 | $100,654.68 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2017
Group/practice field
Penn State Health Medical Group Llc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.